[Modern approach to conservative treatment of benign prostatic hyperplasia].
It has been estimated that more than 30 million of people suffer from the symptoms in the lower urinary tract caused by benign hyperplasia of the prostate. According to data from literature the term benign hyperplasia of the prostate should be reserved only for histological diagnosis. The paper presents contemporary approaches to diagnostics and non-surgical, i.e. conservative modalities of the therapy. These modalities include: follow up of the patients, medicamentous therapy and non-surgical invasive therapies. Medicamentous therapy implies phytotherapy, inhibitors of 5-Alpha reductase and antagonists of Alpha-adrenergic receptors. Non-surgical invasive therapies include: balloon dilatation, ureteral stents and thermotherapy. The paper indicates the place of certain options related to the conservative treatment of benign hyperplasia of the prostate. A fact that only 10% of these patients are treated surgically means that majority of them need other, i.e. conservative therapy. New achievements in the treatment of benign hyperplasia of the prostate have aroused new hope for men suffering from this disease.